Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy

BACKGROUND AND PURPOSE: Adjuvant radiotherapy of internal mammary nodes (IMN) improves survival in high-risk early breast cancer patients but inevitably leads to more dose to heart and lung. Target coverage is often compromised to meet heart/lung dose constraints. We estimate heart and lung dose whe...

Descripción completa

Detalles Bibliográficos
Autores principales: Stick, Line Bjerregaard, Lorenzen, Ebbe Laugaard, Yates, Esben Svitzer, Anandadas, Carmel, Andersen, Karen, Aristei, Cynthia, Byrne, Orla, Hol, Sandra, Jensen, Ingelise, Kirby, Anna M., Kirova, Youlia M., Marrazzo, Livia, Matías-Pérez, Angela, Nielsen, Mette Marie Bruun, Nissen, Henrik Dahl, Oliveros, Sileida, Verhoeven, Karolien, Vikström, Johan, Offersen, Birgitte Vrou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892790/
https://www.ncbi.nlm.nih.gov/pubmed/33659716
http://dx.doi.org/10.1016/j.ctro.2021.01.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892790/
https://www.ncbi.nlm.nih.gov/pubmed/33659716
http://dx.doi.org/10.1016/j.ctro.2021.01.012

Ejemplares similares